Trial Profile
Cross-sectional study to determine real-life concentrations of metformin and/or sitagliptin in patients with type 2 diabetes in dried blood spots
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2022
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 31 Jan 2019 Results published in the European Journal of Clinical Pharmacology
- 01 Aug 2016 Status changed from not yet recruiting to recruiting.
- 01 Aug 2016 New trial record